Skip to main content


Page 6 of 14

  1. Extracorporeal membrane oxygenation (ECMO) support can be life-saving in critically ill COVID-19 patients. However, there are many complications associated with this procedure, including Heparin-induced thromb...

    Authors: Xuan T. Phan, Tuan H. Nguyen, Tung T. Tran, Thu-Hien T. Huynh, Thuy-Ha T. Hoang, Vinh-Chau V. Nguyen and Thao N. T. Pham
    Citation: Thrombosis Journal 2020 18:37
  2. Thromboembolism is one of the main causes of maternal mortality, which can be prevented in many cases. The present study was designed to investigate the incidence and prophylaxis strategies for maternal mortal...

    Authors: Mahboobeh Shirazi, Behrokh Sahebdel, Mahnoosh Torkzaban, Elham Feizabad and Marjan Ghaemi
    Citation: Thrombosis Journal 2020 18:36
  3. Alcohol consumption is associated with haemostasis and so may influence cardiovascular conditions. It is unknown whether the association of alcohol with total and γ’ fibrinogen concentrations, as well as clot ...

    Authors: Petro Hannie Rautenbach, Cornelie Nienaber-Rousseau and Marlien Pieters
    Citation: Thrombosis Journal 2020 18:35
  4. Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, the incidence of thromboembolism has been increasingly reported. The aim of this systematic review was to explore the incidence of venou...

    Authors: Kochawan Boonyawat, Pichika Chantrathammachart, Pawin Numthavaj, Nithita Nanthatanti, Sithakom Phusanti, Angsana Phuphuakrat, Pimjai Niparuck and Pantep Angchaisuksiri
    Citation: Thrombosis Journal 2020 18:34

    The Correction to this article has been published in Thrombosis Journal 2020 18:39

  5. There is a high incidence of deep vein thrombosis (DVT) among cancer patients undergoing chemotherapy. Chemotherapy-induced vascular endothelial cell activation (VECA) is characterized by increased plasma leve...

    Authors: Budi Setiawan, Cecilia Oktaria Permatadewi, Baringin de Samakto, Ashar Bugis, Ridho M. Naibaho, Eko Adhi Pangarsa, Damai Santosa and Catharina Suharti
    Citation: Thrombosis Journal 2020 18:33
  6. Pregnant women are at increased risk of thrombotic adverse events. Plasma derived immune globulin (IG) products, which are used in pregnancy for various indications, may contain procoagulant impurity activated...

    Authors: Yanqun Xu, Yideng Liang, Leonid Parunov, Daryl Despres, Michael Eckhaus, Dorothy Scott, Mikhail Ovanesov and Evi B. Struble
    Citation: Thrombosis Journal 2020 18:32
  7. In the intensive care unit (ICU), patients with thrombocytopenia are at high risk for bleeding and should be assessed for their thrombogenic potential. However, the analytical conditions of conventional hemost...

    Authors: Bengo Atari, Takashi Ito, Tomoka Nagasato, Tomoko Ohnishi, Kazuya Hosokawa, Tomotsugu Yasuda, Ikuro Maruyama and Yasuyuki Kakihana
    Citation: Thrombosis Journal 2020 18:31
  8. Hypertensive disorders of pregnancy are associated with vascular complications, including ischemic stroke and cervical artery dissection. Vertebral artery dissection (VAD), however, is rare. We describe a 31-y...

    Authors: Nicholas T. Manasewitsch, Ahmed A. Hanfy, Bryce D. Beutler, Daniel Antwi-Amoabeng, Moutaz Taha, Mohamed Elnaggar and Gurpreet S. Chahal
    Citation: Thrombosis Journal 2020 18:30
  9. Left ventricular thrombus (LVT) is associated with a significant risk of ischemic stroke (IS) and peripheral embolization. Societal guidelines recommend the use of warfarin, with direct oral anticoagulants (DO...

    Authors: Zafar Ali, Nicholas Isom, Tarun Dalia, Farhad Sami, Uzair Mahmood, Zubair Shah and Kamal Gupta
    Citation: Thrombosis Journal 2020 18:29
  10. Direct endothelial injury by viruses and dysregulation of clotting mechanisms due to cytokine storm are the major precipitating factors of mortality in COVID-19; both are attributed to a fundamental dysregulat...

    Authors: Nobunao Ikewaki, Kosagi-Sharaf Rao, Armando Durant Archibold, Masaru Iwasaki, Rajappa Senthilkumar, Senthilkumar Preethy, Shojiro Katoh and Samuel J. K. Abraham
    Citation: Thrombosis Journal 2020 18:27
  11. This study aimed to investigate the predictive value of the D-dimer level for venous thromboembolism (VTE) events during puerperium of women age at 35 years or older, as well as to identify other risk factors ...

    Authors: Wen Hu, Dong Xu, Juan Li, Cheng Chen, Yuan Chen, Fangfang Xi, Feifei Zhou, Xiaohan Guo, Baihui Zhao and Qiong Luo
    Citation: Thrombosis Journal 2020 18:26
  12. Disseminated intravascular coagulation (DIC) can be correctly redefined as disseminated intravascular microthrombosis based on “two-path unifying theory” of in vivo hemostasis. “DIC” is a form of vascular micr...

    Authors: Jae C. Chang
    Citation: Thrombosis Journal 2020 18:25
  13. Air travel thrombosis continues to be a controversial topic. Exposure to hypoxia and hypobaric conditions during air travel is assumed a risk factor. The aim of this study is to explore changes in parameters o...

    Authors: Anna Levkovsky, Rima Dardik, Daniel Barazany, David M. Steinberg, Mark Dan Kirichenko, Sara Apter, Edna Peleg, Daniel Silverberg, Ehud Grossman and Ophira Salomon
    Citation: Thrombosis Journal 2020 18:24
  14. The role of venous obstructions as a risk factor for recurrent venous thromboembolism has never been evaluated. This study aimed to determine whether there is a difference in prevalence of venous obstructions ...

    Authors: Pascale Notten, Rob H. W. Strijkers, Irwin Toonder, Hugo ten Cate and Arina J. ten Cate-Hoek
    Citation: Thrombosis Journal 2020 18:23
  15. Hospitals in the Middle East Gulf region have experienced an influx of COVID-19 patients to their medical wards and intensive care units. The hypercoagulability of these patients has been widely reported on a ...

    Authors: Bassam Atallah, Wasim El Nekidy, Saad I. Mallah, Antoine Cherfan, Laila AbdelWareth, Jihad Mallat and Fadi Hamed
    Citation: Thrombosis Journal 2020 18:22
  16. Coronavirus disease 2019 (COVID-19) is associated with extreme inflammatory response, disordered hemostasis and high thrombotic risk. A high incidence of thromboembolic events has been reported despite thrombo...

    Authors: M. Hardy, T. Lecompte, J. Douxfils, S. Lessire, J. M. Dogné, B. Chatelain, S. Testa, I. Gouin-Thibault, Y. Gruel, R. L. Medcalf, H. ten Cate, G. Lippi and F. Mullier
    Citation: Thrombosis Journal 2020 18:17
  17. Hemostatic changes and endothelial activations have been recognized in β-thalassemic patients after matched-donor hematopoietic stem cell transplantation (HSCT) but there are limited studies for haploidentical...

    Authors: Surapong Lertthammakiat, Peerasit Sitthirat, Usanarat Anurathapan, Duantida Songdej, Samart Pakakasama, Ampaiwan Chuansumrit, Nattaphat Putawornsub, Sawitt Sirasittikarn, Sataporn Wantanawijarn, Praguywan Kadegasem, Suradej Hongeng and Nongnuch Sirachainan
    Citation: Thrombosis Journal 2020 18:21
  18. Patients infected with SARS-CoV-2 often develop venous and arterial thrombosis. The high patient mortality is partly attributed to thrombotic events. An emerging trend is the presence of immunological phenomen...

    Authors: Michael Tran, Chirag Sheth, Rohan Bhandari, Scott J. Cameron and Deborah Hornacek
    Citation: Thrombosis Journal 2020 18:16
  19. Whether glutathione S-transferase (GST) null polymorphisms, namely GSTM1 null, GSTP1 null and GSTT1 null polymorphisms, influence the risk of coronary artery disease (CAD) or not remains unclear. Thus, the author...

    Authors: Hongling Su, Yunshan Cao, Jing Li, Yan Zhu and Xuming Ma
    Citation: Thrombosis Journal 2020 18:20
  20. Upon vascular damage, the exposed subendothelial matrix recruits circulating platelets to site of injury while inducing their firm adhesion mainly via GPVI-collagen interaction. GPVI also supports aggregatory ...

    Authors: Ehteramolsadat Hosseini, Saba Hojjati, Safoora Afzalniaye gashti and Mehran Ghasemzadeh
    Citation: Thrombosis Journal 2020 18:18
  21. Rivaroxaban has the most available data to support the use of prothrombin complex concentrates (PCC) as a reversal agent. However, PCC might increase the incidence of thrombotic events by shifting the haemosta...

    Authors: Lorine Giffard-Quillon, Helene Desmurs-Clavel, Claire Grange, Yohann Jourdy and Yesim Dargaud
    Citation: Thrombosis Journal 2020 18:15
  22. Anticoagulants are commonly prescribed in medical practices and could be of significant harm in the case of medication errors. We conducted a retrospective observational study to determine the frequency and co...

    Authors: Ramin Rahmanzade, Francisco Cabrera Diaz, Claudia Zaugg, Philipp Schuetz and Ali Reza Salili
    Citation: Thrombosis Journal 2020 18:14
  23. Left atrial septal pouches (LASPs) are a relatively newly described but common anatomical cardiac variant thought to be associated with atrial fibrillation (AF) and cardio-embolic stroke. Blue toe syndrome (BT...

    Authors: Snehasis Pradhan, Kciku Gresa, Jan-Peter Röing genannt Nölke and Hans-Joachim Trappe
    Citation: Thrombosis Journal 2020 18:13
  24. Bechet’s disease (BD) is a relatively rare disease that causes recurrent oral and genital ulcers in addition to a variety of systemic manifestations. Concomitant superior-vena-cava (SVC) thrombosis and cardiac...

    Authors: Ahmed M. Elzanaty, Mohammed T. Awad, Ashu Acharaya, Ebrahim Sabbagh, Eman Elsheikh and Moshrik AbdAlamir
    Citation: Thrombosis Journal 2020 18:12
  25. Although numerous replication case-control studies have attempted to determine the association between Factor V Leiden (FVL) 1691G > A mutation and susceptibility to Recurrent pregnancy loss (RPL), there have ...

    Authors: Mohammad Masoud Eslami, Majid khalili, Mina Soufizomorrod, Saeid Abroun and Bahman Razi
    Citation: Thrombosis Journal 2020 18:11
  26. Dual therapy with a direct oral anticoagulant (DOAC) plus a P2Y12 receptor inhibitor is recommended in patients with nonvalvular atrial fibrillation who undergo percutaneous coronary intervention. Thus, we evalua...

    Authors: Ippei Ikushima, Takaaki Akasaka, Yoshiyuki Morishima, Atsushi Takita, Tomoko Motohashi and Tetsuya Kimura
    Citation: Thrombosis Journal 2020 18:10
  27. Advanced pancreatic ductal adenocarcinoma (aPDAC) patients have a lifetime all type thromboembolic event (ATTE) rate of 25–35%. Efficacy and safety of increased dose primary thromboprophylaxis (IDPTP) with low...

    Authors: Anthony Maraveyas, Farzana Haque, Iqtedar Ahmed Muazzam, Waqas Ilyas and George Bozas
    Citation: Thrombosis Journal 2020 18:9
  28. Venous Thromboembolism (VTE) in cancer patients is associated with increased mortality and morbidity. While newer data on use of direct oral anticoagulants (DOACs) in treating cancer associated thrombosis (CAT...

    Authors: Anadil Faqah, Hassan Sheikh, Muhammad Abu Bakar, Fatima Tayyaab and Sahrish Khawaja
    Citation: Thrombosis Journal 2020 18:8
  29. African Americans are under-represented in trials evaluating oral anticoagulants for the treatment of acute venous thromboembolism (VTE). The aim of this study was to evaluate the effectiveness and safety of r...

    Authors: Olivia S. Costa, Stanley Thompson, Veronica Ashton, Michael Palladino, Thomas J. Bunz and Craig I. Coleman
    Citation: Thrombosis Journal 2020 18:6
  30. For the improvement of AF care, it is important to gain insight into current anticoagulation prescription practices and guideline adherence. This report focuses on the largest Dutch subset of AF-patients, deri...

    Authors: J. Seelig, F. W. A. Verheugt, M. E. W. Hemels, L. Illingworth, A. Lucassen, H. Adriaansen, M. C. M. Bongaerts, M. Pieterse, J. P. R. Herrman, P. Hoogslag, W. Hermans, B. E. Groenemeijer, L. V. A. Boersma, K. Pieper and H. ten Cate
    Citation: Thrombosis Journal 2020 18:5
  31. Pelvic fracture with high energy trauma has a high mortality rate, especially in men. In addition, severe multiple trauma, major hemorrhage, and administration of red blood cells predict mortality in elderly p...

    Authors: Takahito Miyake, Hideshi Okada, Norihide Kanda, Fuminori Yamaji, Haruka Okamoto, Hiroaki Ushikoshi, Kei Noguchi, Hiroyuki Tomita, Shozo Yoshida and Shinji Ogura
    Citation: Thrombosis Journal 2020 18:4
  32. Although disseminated intravascular coagulation (DIC) is life-threatening, any organ failure associated with DIC resolution and outcomes have been unclear.

    Authors: Noriaki Kawano, Hideo Wada, Toshimasa Uchiyama, Kazuo Kawasugi, Seiji Madoiwa, Naoki Takezako, Kei Suzuki, Yoshinobu Seki, Takayuki Ikezoe, Tsuyoshi Hattori and Kohji Okamoto
    Citation: Thrombosis Journal 2020 18:2
  33. Pulmonary embolism (PE) is a disease with a significant impact on public health. However, international epidemiological data are unclear and show considerable heterogeneity. The present study aims to investiga...

    Authors: Dimitrios G. Raptis, Konstantinos I. Gourgoulianis, Zoe Daniil and Foteini Malli
    Citation: Thrombosis Journal 2020 18:1
  34. Venous thromboembolism (VTE) accounts for an estimated 900,000 cases per year in the US alone and constitutes a considerable burden on healthcare systems across the globe.

    Authors: Benjamin Brenner, Roopen Arya, Jan Beyer-Westendorf, James Douketis, Russell Hull, Ismail Elalamy, Davide Imberti and Zhenguo Zhai
    Citation: Thrombosis Journal 2019 17:24
  35. Use of LMWH in pregnancy is not only limited to VTE management, but it extends, to the management of vascular gestational complications and the optimization of IVF pregnancies despite the lack of concrete scie...

    Authors: E. Papadakis, A. Pouliakis, Α. Aktypi, A. Christoforidou, P. Kotsi, G. Αnagnostou, A. Foifa and E. Grouzi
    Citation: Thrombosis Journal 2019 17:23
  36. We aimed to compare effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin-K antagonists (VKA) in atrial fibrillation (AF) patients with chronic kidney disease (CKD) no...

    Authors: Emma Kirstine Laugesen, Laila Staerk, Nicholas Carlson, Anne-Lise Kamper, Jonas Bjerring Olesen, Christian Torp-Pedersen, Gunnar Gislason and Anders Nissen Bonde
    Citation: Thrombosis Journal 2019 17:21
  37. Following the publication of this article [1], the authors reported an incorrect citation in the following sentence in the “Metalloproteases” sub-section:

    Authors: Dorothea M. Heuberger and Reto A. Schuepbach
    Citation: Thrombosis Journal 2019 17:22

    The original article was published in Thrombosis Journal 2019 17:4

  38. Physiologically, upon platelet activation, uncontrolled propagation of thrombosis is prevented by regulating mechanisms which affect the expression and function of either platelet adhesion receptors or integri...

    Authors: Ehteramolsadat Hosseini, Maryam Mohtashami and Mehran Ghasemzadeh
    Citation: Thrombosis Journal 2019 17:20
  39. Our objective was to study the phenotype of and molecular genetic mechanisms underlying congenital protein C (PC) deficiency in Chinese neonates. We report the case of a neonate who presented 4 h after birth w...

    Authors: Xiaoying Li, Xiaoyan Li, Xiao Li, Yuanhua Zhuang, Lili Kang and Xiuli Ju
    Citation: Thrombosis Journal 2019 17:19
  40. Atypical hemolytic uremic syndrome is a rare group of disorders that have in common underlying complement amplifying conditions. These conditions can accelerate complement activation that results in a positive...

    Authors: Ramy M. Hanna, Noah Merin, Richard M. Burwick, Lama Abdelnour, Umut Selamet, Beshoy Yanny, Patrick Bui, Mary Fouad and Ira Kurtz
    Citation: Thrombosis Journal 2019 17:18
  41. Thrombus formation is an important factor affecting cardiovascular events and venous thromboembolism in type 2 diabetes. However, it is unclear whether glycemic control reduces thrombogenicity. We investigated...

    Authors: Kiyoaki Yamamoto, Takashi Ito, Tomoka Nagasato, Atsushi Shinnakasu, Mihoko Kurano, Aiko Arimura, Hiroshi Arimura, Hiroshi Hashiguchi, Takahisa Deguchi, Ikuro Maruyama and Yoshihiko Nishio
    Citation: Thrombosis Journal 2019 17:17
  42. Bridging anticoagulation is used in vitamin-K antagonist (VKA) patients undergoing invasive procedures and involves complex risk assessment in order to prevent thromboembolic and bleeding outcomes.

    Authors: M. J. Moesker, J. F. de Groot, N. L. Damen, N. R. Bijsterveld, J. W. R. Twisk, M. V. Huisman, M. C. de Bruijne and C. Wagner
    Citation: Thrombosis Journal 2019 17:15
  43. Ambulatory management of isolated acute deep venous thrombosis (DVT) is the recommended standard of care in selected populations. However, in practice a significant number of patients continue to be managed as...

    Authors: Sarah Kelliher, Patricia Hall, Barry Kevane, Daniela Dinu, Karl Ewins, Peter MacMahon, Fionnuala Ní Áinle and Tomás Breslin
    Citation: Thrombosis Journal 2019 17:14
  44. Although patients with acute myeloid leukemia (AML) were shown to have an increased risk of thrombosis, no thrombosis risk assessment scoring system has been developed for AML patients. The Khorana Risk Score ...

    Authors: Abu-Sayeef Mirza, Seongseok Yun, Najla Al Ali, Hannah Shin, Joseph Luke O’Neil, Maher Elharake, Daniel Schwartz, Katherine Robinson, Ethan Nowell, Grace Engle, Ibraahim Badat, Thomas Brimer, Amra Kuc, Ashton Sequeira, Sabbir Mirza, Dhiraj Sikaria…
    Citation: Thrombosis Journal 2019 17:13
  45. The usefulness of the activated partial thromboplastin time (APTT) waveform has been reported in hemophilia, acquired hemophilia and monitoring for anticoagulants.

    Authors: Kei Suzuki, Hideo Wada, Takeshi Matsumoto, Makoto Ikejiri, Kohshi Ohishi, Yoshiki Yamashita, Hiroshi Imai, Toshiaki Iba and Naoyuki Katayama
    Citation: Thrombosis Journal 2019 17:12

Official journal of

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

    Members of APSTH are entitled to a 15% discount on the article processing charge.

Annual Journal Metrics